Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention Reply

被引:1
|
作者
You, Seng Chan [1 ]
Gupta, Aakriti [2 ]
Krumholz, Harlan M. [3 ]
机构
[1] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, South Korea
[2] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Div Cardiol, New York, NY USA
[3] Yale Sch Med, Sect Cardiovasc Med, One Church St,Ste 200, New Haven, CT 06510 USA
来源
关键词
OPEN-LABEL;
D O I
10.1001/jama.2020.26023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:890 / 891
页数:2
相关论文
共 50 条
  • [21] Prasugrel or Ticagrelor for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Does it Matter?
    Giri, Jay
    Nathan, Ashwin
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (16) : 1587 - 1589
  • [22] Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes
    Koshy, Anoop N.
    Giustino, Gennaro
    Sartori, Samantha
    Hooda, Amit
    Feng, Yihan
    Snyder, Clayton
    Dasgupta, Shabitri
    Kumar, Kartik R.
    Krishnamoorthy-Melarcode, Parasuram
    Sweeny, Joseph
    Khera, Sahil
    Serrao, Gregory W.
    Sharma, Raman
    Dangas, George
    Kini, Annapoorna S.
    Mehran, Roxana
    Sharma, Samin K.
    EUROINTERVENTION, 2023, 18 (15) : 1244 - +
  • [23] Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
    Zheng, Wei
    Li, Youmei
    Tian, Jingdu
    Li, Lufeng
    Xie, Li
    Mao, Qi
    Tong, Wuyang
    Zhou, Denglu
    Azzalini, Lorenzo
    Zhao, Xiaohui
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [24] EFFECT OF TICAGRELOR AND CLOPIDOGREL ON PLATELET AGGREGATION FUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Sui, Z.
    Qu, P.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (02): : 439 - 445
  • [25] Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Wang, He-Yang
    Li, Yi
    Xu, Xiao-Ming
    Li, Jing
    Han, Ya-Ling
    CHINESE MEDICAL JOURNAL, 2018, 131 (17) : 2017 - +
  • [26] Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    He-Yang Wang
    Yi Li
    Xiao-Ming Xu
    Jing Li
    Ya-Ling Han
    中华医学杂志(英文版), 2018, 131 (17) : 2017 - 2024
  • [27] P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Chen, Po-Wei
    Feng, Wen-Han
    Ho, Ming-Yun
    Su, Chun-Hung
    Huang, Sheng-Wei
    Cheng, Chung-Wei
    Yeh, Hung-, I
    Chen, Ching-Pei
    Huang, Wei-Chun
    Fang, Ching-Chang
    Lin, Hui-Wen
    Lin, Sheng-Hsiang
    Hsieh, I-Chang
    Li, Yi-Heng
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [28] Ticagrelor as Compared to Clopidogrel Following Percutaneous Coronary Intervention for Acute
    Wiens, Evan J.
    Leon, Silvia J.
    Whitlock, Reid
    Tangri, Navdeep
    Shah, Ashish H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 198 : 26 - 32
  • [29] Ticagrelor or clopidogrel in atrial fibrillation patients undergoing percutaneous coronary intervention for myocardial infarction
    Godtfredsen, S. J.
    Kragholm, K. H.
    Bekfani, T.
    Sorensen, R.
    Torp-Pedersen, C.
    Bhatt, D. L.
    Pareek, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [30] Ticagrelor versus prasugrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An unresolved issue
    Savarese, Gianluigi
    Lund, Lars H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 249 : 77 - 78